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Abstract
The physiological environment which hosts the conformational conversion of the cellular prion protein (PrP
C) to disease-
associated isoforms has remained enigmatic. A quantitative investigation of the PrP
C interactome was conducted in a cell
culture model permissive to prion replication. To facilitate recognition of relevant interactors, the study was extended to
Doppel (Prnd) and Shadoo (Sprn), two mammalian PrP
C paralogs. Interestingly, this work not only established a similar
physiological environment for the three prion protein family members in neuroblastoma cells, but also suggested direct
interactions amongst them. Furthermore, multiple interactions between PrP
C and the neural cell adhesion molecule, the
laminin receptor precursor, Na/K ATPases and protein disulfide isomerases (PDI) were confirmed, thereby reconciling
previously separate findings. Subsequent validation experiments established that interactions of PrP
C with PDIs may extend
beyond the endoplasmic reticulum and may play a hitherto unrecognized role in the accumulation of PrP
Sc. A simple
hypothesis is presented which accounts for the majority of interactions observed in uninfected cells and suggests that PrP
C
organizes its molecular environment on account of its ability to bind to adhesion molecules harboring immunoglobulin-like
domains, which in turn recognize oligomannose-bearing membrane proteins.
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Introduction
Prions are the causative agents underlying a range of rare but
invariably fatal neurodegenerative diseases in humans and other
mammals. In disease, the cellular prion protein (Prnp; herein
referred to as PrP
C) converts to a disease-associated conformer
(PrP
Sc) with different physicochemical properties [1]. PrP
C is a
relatively small protein which assembles into an unstructured N-
terminal domain and a globular C-terminal half characterized by
the presence of an internal disulfide bridge, up to two N-linked
glycans and a glycosylphosphatidylinositol (GPI) anchor for
insertion into the cellular plasma membrane. Multiple lines of
investigation have led to the conclusion that mature PrP
C is
embedded in specialized membrane domains, so-called raft-like
domains, rich in cholesterol and sphingolipids [2]. It has been
suggested that these raft-like domains host the self-perpetuated
accumulation of PrP
Sc which subsequently triggers a poorly-
understood cascade of events that ultimately leads to cell death.
Whereas significant progress has been made in the past few years
in defining the minimal requirements for PrP
C conversion in vitro
[3], the molecular environment which hosts the earliest steps in
prion disease manifestation in neuronal cells remains enigmatic.
This shortcoming is not due to a lack of proteins proposed to
interact directly with PrP
C. In fact, more than three dozen proteins
have been suggested to reside in spatial proximity to PrP
C using
multiple experimental paradigms [4]. Additional candidate
interactors have been proposed to bind preferentially to PrP
Sc
[5,6,7]. In surveying this body of literature, however, it is apparent
that very few of the candidate interactors have been independently
verified by multiple investigators and, overall, little agreement
exists as to their relative importance for prion protein biology.
Notable exceptions may represent the 37-kDa/67-kDa laminin
receptor precursor (herein referred to as LRP; also known as
ribosomal protein SA (Rpsa), and not to be confused with Lrp1,
the low density lipoprotein receptor-related protein 1) [8], one of
the first proteins identified to bind to the prion protein in a yeast
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(Ncam1; herein referred to as NCAM), which was initially
identified in a cellular crosslinking study based on a co-
immunoprecipitation methodology [10]; and heparin sulfate
proteoglycans (HSPGs) [11,12]. Since its original discovery, LRP
has been proposed to act as a cell surface receptor for PrP
C that
may play a role in prion propagation [13]. In the case of NCAM,
binding to PrP has been shown to play a role in neuritic outgrowth
possibly mediated through an interaction with Fyn tyrosine kinase
[14,15].
In studying the molecular environment of membrane proteins, a
limitation exists in that the proteins must be solubilized by the
addition of detergents in a manner that does not disrupt the
protein-protein interactions under investigation. A solution to this
obstacle constitutes the covalent stabilization of interactions by
chemical crosslinking prior to the disruption of cellular integrity.
In this regard, we previously reported on a large-scale investigation
of the molecular PrP
C neighborhood in mice following limited in
vivo crosslinking by time-controlled transcardiac perfusion (tcTPC)-
based delivery of formaldehyde (FA) to the brain [16]. A
conspicuous feature of this PrP
C interactome dataset was the
relative abundance of membrane proteins which harbor immu-
noglobulin (Ig)-like folding motifs in their extracellular domains
confirming previous data describing a binding domain of PrP
C
within these folds [10].
Given the large diversity of cell types present in the brain, we
questioned whether an equivalent concentration of Ig-like domain-
harboring proteins would have been found if the investigation of
the PrP
C interactome had been restricted to a single cell type. A
particular concern was that the relative abundance of Ig-like
domain-harboring proteins in the previous dataset may have
masked the ability to identify biologically important interactions of
PrP
C that are more transient in nature or involve less abundant
proteins. We therefore chose to reinvestigate the PrP
C interactome
in mouse neuroblastoma cells (N2a), which are by far the best-
characterized cell model for the study of the biology and
conversion of PrP
C to PrP
Sc [17,18]. To facilitate the discrimina-
tion of unspecific binders from specific interactors in this study, we
incorporated quantitative mass spectrometry based on isotopic
labeling and extended our investigation to the mammalian PrP
C
paralogs Doppel (encoded by the Prnd gene; protein product
herein referred to as Dpl) and Shadoo (encoded by the Sprn gene;
protein product herein referred to as Sho). To avoid the use of
non-identical affinity chromatography steps, we equipped the
three bait proteins with the same N-terminal FLAG epitope [19],
with the awareness that a similar PrP
C expression construct had in
prior investigations neither interfered with the posttranslational
processing nor the conversion of PrP
C in cell or animal models
[18]. We now present data which suggest that members of the
mammalian prion protein family may populate highly similar
molecular environments when expressed in the neuroblastoma cell
model system. We further document that a subset of endoplasmic
reticulum (ER) chaperones which interact strongly with PrP
C
escape from the ER to reside in spatial proximity to PrP
C at the
plasma membrane. Pharmacological inhibition of these chaper-
ones could increase PrP
Sc levels in prion-infected N2a sublines,
suggesting a protective role for the chaperones in this paradigm.
Finally, our data consolidate multiple previously controversial
interactions and suggest a scenario whereby PrP
C may organize its
molecular environment by its ability to recognize a specialized
subset of cell adhesion molecules which recruit membrane proteins
carrying high-mannose glycans into spatial proximity with PrP
C.
Results
Large-scale quantitative and comparative interactome
investigation of members of the mammalian prion
protein family
In preparation for this study, mouse neuroblastoma cells (N2a)
stably expressing N-terminally FLAG-tagged full-length versions of
Dpl, PrP and Sho were generated (Fig. 1). Small-scale expression
tests followed by diagnostic N-glycosidase F or phosphatidylino-
sitol-specific phospholipase C digestions confirmed that all three
bait proteins mimicked their untagged parent molecules in (i) the
presence of N-glycans, and (ii) membrane attachment by means of
a GPI anchor [20] (and data not shown). To generate the
biological source material for a large-scale comparative inter-
actome investigation, the three cell lines and an ‘‘empty-vector’’
stably-transfected N2a cell line serving as a negative control were
expanded to 10
9 cells each using cell culture conditions which
promote adherent growth. To covalently stabilize protein-protein
interactions prior to the disruption of cellular integrity, cells were
subjected to a 15-min treatment with FA [10]. Subsequently, cells
were lysed by the addition of detergents and the four extracts (each
containing approximately 500 mg of cellular protein) purified side-
by-side on anti-FLAG affinity agarose matrices. The presence of
covalent linkages between proteins permitted the use of highly
stringent washing conditions to minimize the presence of
unspecific binders. Following elution from the affinity matrix
(with a yield of approximately 100 mg of protein material per
sample), protein complexes were denatured and trypsinized.
Finally, peptide mixtures were tagged with isobaric tags for
relative and absolute quantitation (iTRAQ) [21], and the samples
were combined and subjected to a comprehensive analysis by
tandem mass spectrometry (MS/MS) (Fig. 2). A query of mouse
protein databases led to the identification of more than 100
proteins. All identifications can be considered confident by
multiple measures: (i) identical identifications were made by two
matching algorithms; (ii) scores assigned by the algorithms
exceeded significance thresholds (P,0.05) for all identifications
and were based on a minimum of two peptides; and (iii) a search of
a decoy database generated by the inversion of sequences for all
Author Summary
Prions underlie rare but invariably fatal neurodegenerative
diseases in humans and other mammals. Public awareness
of these diseases has grown with the occurrence of cases
of BSE (also known as ‘‘Mad Cow Disease’’) and the
realization that this disease can, in rare instances, be
transmitted to humans. The normal cellular prion protein is
found in most cell types within the body. In disease, this
protein acquires a different shape which tends to
aggregate and poison nearby cells. The disease-associated
conversion of the prion protein appears to require its
localization to specialized cellular membrane regions rich
in cholesterol; however, the precise molecular environ-
ment which hosts this event has remained elusive. We
used a cell-based disease model to identify proteins which
reside in close proximity to the prion protein and two
closely related mammalian proteins. We demonstrate that
these three proteins may not only populate highly similar
environments but may also interact with each other. We
further identified an extended molecular network in
proximity of these proteins which supports functions in
adhesion control, lactate metabolism and cell fusion
events. It is anticipated that these insights will contribute
to efforts to rationally interfere with aberrant protein-
protein interactions underlying these diseases.
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any of the above features [22]. A reduction of the total list of
identified proteins to the subset of proteins whose identification
correlated with the presence of at least one of the three bait
proteins was based on peak intensities of iTRAQ reporter ions
found in the low mass range of individual collision induced
dissociation (CID) spectra. The relative intensity of these ions is
indicative of the relative contribution of each of the iTRAQ-
labeled samples to the generation of a given CID spectrum. Thus,
by calculating the ratio of reporter ion intensities for each of the
three bait-specific reporter ions (iTRAQ 115: Dpl; iTRAQ 116:
PrP; iTRAQ 117: Sho) and the negative control ion (iTRAQ 114
reporter), peptides purifying with at least one of the three baits
were recognized by iTRAQ reporter ion ratios greater than 1. The
above analysis revealed that more than 50 proteins co-purified
with at least one of the three bait proteins (Table 1). Interestingly,
the majority of these proteins co-purified with all three bait
proteins, suggesting that the molecular environment of the three
members of the mammalian prion protein family assessed in the
context of mouse neuroblastoma cells is highly similar.
We next explored the known cellular localization of candidate
interactors based on bioinformatic methods and literature mining.
This investigation revealed that multiple proteins in the dataset
were likely to encounter the three bait proteins during their early
passage through the secretory pathway, since they constitute (i)
classical ER chaperones (heat shock protein 5, Hspa5; calnexin,
Canx; calreticulin, Calr; endoplasmin, Hsp90b1), (ii) isomerases
which facilitate disulfide or proline cis-trans rearrangements
(protein disulfide isomerase associated 3, Pdia3; protein disulfide
isomerase associated 4, Pdia4; prolyl 4-hydroxylase beta polypep-
tide, P4hb; peptidylprolyl isomerase B, Ppib), or (iii) proteins
involved in the trafficking between ER and Golgi compartments
(transmembrane emp24 transport domain containing 9, Tmed9;
and transmembrane emp24-like trafficking protein 10, Tmed10).
Other proteins in the dataset were likely to reside in spatial
proximity to the mature bait proteins at the plasma membrane,
because they are themselves known to be either (iv) embedded in
the plasma membrane through transmembrane (TM) domains
(NCAM; transferrin receptor, Tfrc; integrins; neuropilin 1, Nrp1;
L1 cell adhesion molecule, L1cam; basigin, Bsg), or constitute (v)
secreted proteins (galectin-1, Lgals1; family with sequence
similarity 3, member C, Fam3c; ectonucleotide pyrophospha-
Figure 1. Expression analysis of FLAG-tagged mouse prion proteins. A, Schematic representation of murine prion proteins with FLAG tags
inserted near the N-terminus. B, Expression of transiently-transfected FLAG-prion proteins in N2a cells as assessed by Western blotting with the anti-
FLAG M2 antibody. The presence of a non-specific band in N2a lysates recognized by the M2 antibody is denoted by an asterisk.
doi:10.1371/journal.ppat.1000608.g001
Figure 2. Flow chart depicting strategy for semi-quantitative
comparison of prion protein family interactomes. In vivo
formaldehyde crosslinked protein complexes containing N-terminally
FLAG-tagged bait proteins are stringently purified on anti-FLAG agarose
parallel to a negative control sample derived from an empty vector
expression clone. Following alkylation, reduction and trypsinization,
digests are side-by-side iTRAQ labeled and subsequently combined.
Two-dimensional liquid chromatography of peptides is coupled to
online ESI-MS/MS, which is followed by computationally-aided protein
identification and quantitative analysis.
doi:10.1371/journal.ppat.1000608.g002
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IPI accession number Symbol Identified proteinsa Pept.b Uniquec % Cov.d 114 115 116 117
Control
e Dpl PrP Sho
IPI:IPI00131622.1 Prnd prion protein dublet (doppel, Dpl) 8 13 39.1 2.0 92.5 3.0 2.5
IPI:IPI00120793.1 Prnp prion protein (PrP) 5 5 26.8 4.0 20.5 65.1 10.5
IPI:IPI00226455.1 Sprn shadow of prion protein (shadoo, Sho) 3 6 69.4 2.9 11.4 20.5 65.2
IPI:IPI00751369.1 Ldha lactate dehydrogenase A 15 19 67.3 6.0 26.3 44.0 23.7
IPI:IPI00230108.6 Pdia3 protein disulfide isomerase associated 3 14 15 61.2 6.0 46.7 18.8 28.4
IPI:IPI00229517.5 Lgals1 galectin-1 (lectin, galactose binding, soluble 1) 5 7 57.8 5.3 32.8 37.4 24.4
IPI:IPI00122971.1 Ncam1 neural cell adhesion molecule 1 (NCAM) 23 34 54.3 3.4 58.6 16.6 21.3
IPI:IPI00670985.3 Gm9234 predicted gene 9234 (EG668548) 6 6 53.7 13.6 29.8 36.7 20.0
IPI:IPI00128973.1 Gap43 growth associated protein 43 (neuromodulin) 2 2 46.7 7.0 30.5 24.5 38.0
IPI:IPI00850840.1 Rpsa ribosomal protein SA (laminin receptor precursor, LRP) 7 8 43.4 11.8 33.8 26.9 27.5
IPI:IPI00319992.1 Hspa5 heat shock protein 5 15 20 42.7 7.4 32.9 22.5 37.3
IPI:IPI00515173.1 H2-K1 histocompatibility 2, K1, K region 6 6 40.6 3.6 60.9 17.0 18.5
IPI:IPI00762203.2 Ftl1 ferritin light chain 1 3 4 39.9 10.4 36.9 29.4 23.3
IPI:IPI00454042.2 Fam3c family with sequence similarity 3, member C 4 4 35.7 4.7 64.4 12.5 18.5
IPI:IPI00133522.1 P4hb protein disulfide-isomerase (prolyl 4-hydroxylase beta) 8 9 35.4 5.7 22.5 28.4 43.4
IPI:IPI00135686.2 Ppib peptidylprolyl isomerase B 4 4 34.3 10.3 30.3 24.2 35.1
IPI:IPI00132950.1 Rps21 ribosomal protein S21 2 2 31.3 8.6 18.7 37.9 34.9
IPI:IPI00110805.1 H2-D1 histocompatibility 2, D region locus 1 5 5 29.3 3.4 56.7 19.9 20.0
IPI:IPI00119618.1 Canx calnexin precursor 8 8 28.8 7.1 40.7 18.8 33.4
IPI:IPI00554929.2 Hsp90ab1 heat shock protein 90 alpha (cytosolic), class B member 1 10 11 28.6 11.5 15.6 33.4 39.6
IPI:IPI00123639.1 Calr calreticulin 3 3 27.9 7.2 32.5 24.7 35.6
IPI:IPI00116498.1 Ywhaz 14-3-3 protein zeta 4 5 27.8 10.0 21.6 35.4 33.0
IPI:IPI00462199.1 Bsg basigin 5 5 27.3 4.1 32.0 23.2 40.7
IPI:IPI00230682.6 Ywhab 14-3-3 protein beta 2 2 27.0 10.5 26.3 23.4 39.8
IPI:IPI00857709.1 Tmed2 transmembrane emp24 domain trafficking protein 2 2 2 26.9 6.0 33.6 26.1 34.4
IPI:IPI00854971.1 Pdia6 protein disulfide isomerase associated 6 2 2 25.6 7.8 29.5 27.9 34.9
IPI:IPI00466570.4 Tmed10 transmembrane emp24-like trafficking protein 10 4 5 25.1 3.5 35.7 16.8 44.0
IPI:IPI00230707.6 Ywhag 14-3-3 protein gamma 2 2 23.9 9.8 12.0 48.7 29.6
IPI:IPI00132799.4 C1qbp complement component 1, q subcomponent binding protein 4 4 23.3 9.8 17.4 22.2 50.7
IPI:IPI00124700.1 Tfrc transferrin receptor protein 1 5 5 22.4 6.6 49.4 19.1 24.9
IPI:IPI00129526.1 Hsp90b1 heat shock protein 90, beta (Grp94), member 1 (endoplasmin) 3 3 20.9 7.7 23.4 28.7 40.2
IPI:IPI00123342.4 Hyou1 hypoxia up-regulated 1 2 2 20.6 10.4 25.3 31.4 32.9
IPI:IPI00762435.2 Fyn fyn proto-oncogene 3 3 20.5 13.3 24.2 28.6 33.9
IPI:IPI00129519.3 Basp1 brain abundant, membrane attached signal protein 1 7 10 19.9 8.2 18.8 37.4 35.5
IPI:IPI00187289.2 Tmem206 transmembrane protein 206 (C1orf75) 2 2 18.9 3.5 18.2 11.1 67.2
IPI:IPI00416577.1 Gdi2 guanosine diphosphate (GDP) dissociation inhibitor 2 2 2 18.8 6.3 32.8 28.0 33.0
IPI:IPI00132474.3 Itgb1 integrin beta 1 5 5 18.4 7.1 33.3 28.1 31.6
IPI:IPI00265291.6 Enpp1 ectonucleotide pyrophosphatase/phosphodiesterase 1 4 4 18.3 9.5 37.6 24.2 28.7
IPI:IPI00114641.2 Slc3a2 solute carrier family 3, member 2 (CD98) 2 4 18.2 10.2 43.6 21.4 24.8
IPI:IPI00420835.3 Itga6 integrin alpha 6 3 3 15.6 8.1 40.2 20.6 31.1
IPI:IPI00762897.1 Ugcgl1 UDP-glucose ceramide glucosyltransferase-like 1 3 3 15.5 7.4 30.0 32.4 30.1
IPI:IPI00115546.4 Gnao1 guanine nucleotide binding protein, alpha O 2 2 15.3 10.1 32.6 27.3 29.9
IPI:IPI00120245.1 Itgav integrin alpha V 2 2 14.5 9.0 37.4 23.5 30.1
IPI:IPI00311682.5 Atp1a1 sodium/potassium transporting ATPase alpha 1 polypeptide 3 3 14.2 6.5 43.3 19.0 31.2
IPI:IPI00124221.1 Atp1b3 sodium/potassium transporting ATPase beta 3 polypeptide 3 4 13.7 5.1 33.9 28.3 32.7
IPI:IPI00652902.1 Gnai2 guanine nucleotide binding protein, alpha inhibiting 2 2 2 13.5 5.1 35.8 24.3 34.8
IPI:IPI00271951.5 Pdia4 protein disulfide isomerase associated 4 4 4 13.3 10.1 25.1 27.0 37.8
IPI:IPI00123996.1 Nrp1 neuropilin 1 2 3 12.8 7.0 49.3 19.6 24.1
IPI:IPI00752565.1 Igsf8 immunoglobulin superfamily, member 8 3 3 12.2 4.8 49.0 21.2 25.0
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(14-3-3 proteins zeta/beta/gamma, Ywhaz/Ywhab/Ywhag; gua-
nine nucleotide binding proteins, Gnao1/Gnai2/Gna13; and Fyn
proto-oncogene) that attach to the plasma membrane from outside
or within the cell, respectively (Fig. 3). In contrast to the above
proteins that were designated as specific interactors by their
iTRAQ reporter ion ratios, proteins which were equally
represented in control and specific interactome cells and therefore
constituted unspecific binders could be mapped to a wide range of
cellular compartments including the nucleus and mitochondria.
This result was expected based on the known cellular biology of
PrP
C and therefore served as strong biological validation of the
iTRAQ-based discrimination of specific interactors from unspe-
cific contaminants.
Interactions amongst members of the mammalian prion
protein family
It was anticipated that iTRAQ reporter ion signals in CID
spectra derived from tryptic peptides of the three bait proteins
would reflect the logic of the iTRAQ conjugation step. For
example, CID spectra which supported the identification of Dpl
had to be mainly contributed by the sample which was labeled
with the iTRAQ 115 reagent. A close inspection of the low mass
range of CID spectra confirmed that this expectation was met for
all three bait proteins and thereby served as an internal control for
the reliability with which relative iTRAQ reporter ion intensities
could be employed to trace the contribution of samples to the
identification of proteins (Table 1). Interestingly, however, a closer
inspection of the above spectra also revealed that approximately
one-third of the peptides which supported the identification of PrP
were contributed by the FLAG-Dpl and FLAG-Sho affinity
purified samples. This observation was supported by five CID
spectra consistent with the interpretation that the purification of
FLAG-Dpl and FLAG-Sho caused a significant co-purification of
endogenous wild-type (wt) PrP
C (P,0.05). A similar co-purifica-
tion of endogenous wt Sho in N2a cells was observed with FLAG-
Dpl and FLAG-PrP. A co-purification of wt Dpl with FLAG-PrP
and FLAG-Sho baits was neither observed nor expected because
no endogenous expression of Dpl can be reliably detected in N2a
cells (or indeed in the adult mouse central nervous system) [23].
Taken together, these data suggest that PrP, Dpl and Sho are
capable of residing in close spatial proximity at the cell membrane
and may engage in reciprocal contacts with each other.
Direct versus indirect PrP interactors
It is unlikely that members of the mammalian prion protein
family engage in direct interactions with all candidate interactors
we identified. For example, some retrieved proteins may represent
complexes of the type PrP
C- crosslink - interactor 1 - crosslink -
interactor 2. Such indirect interactors are often less strongly
represented in such datasets, due to both the non-stoichiometric
crosslinking that can be achieved and the stringent washing
conditions applied. A good correlate for the relative abundance of
a protein in proteomics investigations of this nature is the sequence
coverage with which it was identified. Based on this rationale, the
three bait proteins may bind directly to lactate dehydrogenase
(Ldha), protein disulfide isomerases Pdia3 and P4hb, galectin-1,
NCAM, Gm9234 (also known as EG668548), neuromodulin
(Gap43), LRP and its ribosomal protein partner Rps21, heat shock
proteins Hspa5 and Hsp90ab1, histocompatibility antigens H2-K1
and H2-D1, Fam3c, Ppib, calnexin, calreticulin, 14-3-3 zeta/delta
and basigin, as these proteins were identified with the highest
sequence coverage (25–75%).
Due to their relatively small size, members of the mammalian
prion protein family would be expected to contain a small number
of distinct surface domains that can engage in direct protein-
protein interactions. Consequently, at least a subset of binders may
bind to the same face within the bait proteins and may even
resemble each other in their primary structure or structural folds.
When candidate interactors were subjected to scrutiny from this
angle, similarities between NCAM and basigin, two of the proteins
represented with the highest sequence coverage in the dataset,
became apparent. Not only do both proteins harbor Ig-like
domains, but a subset of these domains bear a striking resemblance
IPI accession number Symbol Identified proteinsa Pept.b Uniquec % Cov.d 114 115 116 117
Control
e Dpl PrP Sho
IPI:IPI00118569.1 Gna13 guanine nucleotide binding protein, alpha 13 3 3 10.1 14.6 35.1 32.8 17.6
IPI:IPI00845689.1 Tmed9 transmembrane emp24 transport domain containing 9 (gp25L2) 5 7 9.7 7.2 44.2 26.1 22.5
IPI:IPI00469000.4 Slc39a6 metal ion transporter ZIP6 3 3 7.3 3.2 29.9 32.8 34.2
IPI:IPI00458003.1 Enpp3 ectonucleotide pyrophosphatase/phosphodiesterase 3 2 2 5.4 5.9 43.4 25.1 25.5
IPI:IPI00273801.3 Slc39a10 metal ion transporter ZIP10 2 2 4.3 2.4 36.3 16.7 44.6
IPI:IPI00831568.1 L1cam L1 cell adhesion molecule 3 3 3.5 10.9 30.9 26.7 31.5
aCandidate interactors are listed in order, with the position of a given protein in the table reflecting the percentage of primary structure corresponding to the combined
unique CID spectra. In instances where a subset of CID spectra were matched to more than one isoform or member of a protein family, only the highest scoring entry
was selected unless an independent identification was supported by at least two unique CID spectra. Proteins were sorted into specific versus unspecific binder
categories based on their iTRAQ distribution, i.e. proteins were considered unspecific interactors if their derived CID spectra revealed iTRAQ114 signature mass peak
signal intensities which exceeded 15% of combined and normalized (100%) intensities for iTRAQ114-117 mass peaks. Only specific interactors are shown in this table.
The complete dataset can be viewed in Table S1.
bOnly CID spectra underlying different peptides were considered, i.e. if the same peptide was identified with different charge states or modifications it counted as one
hit.
cTotal number of unique CID spectra. Please note that the same peptide was only counted more than once if it was identified with different charge states or
modifications.
dPercent sequence coverage based on the presence of peptides for which no higher ranked assignment to other proteins could be made.
eFor the calculation of iTRAQ values the intensity of individual peptide associated iTRAQ signature peaks was normalized to combine to 100% per peptidea n d
subsequently averaged. Standard deviations were determined and are listed in Table S1.
Bait proteins are shown in bold font.
doi:10.1371/journal.ppat.1000608.t001
Table 1. Cont.
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Interestingly, these very same Ig-like domains are capable of
binding to membrane proteins carrying oligomannosidic N-
glycans [26,27,28,29]. The latter modification is only found on a
relatively small number of mature N-glycosylated proteins
expressed mainly in the brain, because oligomannose structures
typically represent transient intermediates subject to additional
posttranslational modification during their passage through the
secretory pathway [26,29,30]. Amongst the few known proteins
carrying oligomannosidic N-glycan structures are the cell adhesion
molecule L1, the b-subunit of the Na/K ATPase, the transferrin
receptor, integrins [31] and members of the ectonucleotide
pyrophosphatase/phosphodiesterase protein family [30]. Remark-
ably, not only were all the above proteins present in our dataset,
but their iTRAQ ratios also documented their specific co-
purification with members of the mammalian prion protein
family. In light of the relatively low sequence coverage observed
for proteins carrying oligomannosidic N-glycans, their presence in
the dataset likely reflects indirect binding to the bait proteins
mediated by the mentioned molecules that harbor Ig-like domains
with an affinity for oligomannosidic N-glycans.
PrP forms high-molecular weight complexes with
proteins carrying oligomannosidic N-glycans
To investigate whether PrP
C also resides in spatial proximity to
membrane proteins equipped with oligomannosidic N-glycans in
the mouse brain, we subjected anaesthetized wild-type mice to
brief crosslinking with formaldehyde to stabilize protein-protein
interactions in vivo prior to the disruption of cellular integrity [16].
Perfused mouse brains were then rapidly dissected and homog-
enized in the presence of a quenching reagent. To verify the
success of the crosslinking reaction and characterize the size
distribution of crosslinked protein complexes containing PrP
C an
aliquot of extracts was passed through a pre-calibrated size-
exclusion chromatography column. This pilot analysis document-
ed that PrP
C was found in protein complexes co-eluting with
calibration markers which span a range of 160 kDa to 669 kDa.
Uncrosslinked PrP
C could be recovered from the crosslinked
complexes by a crosslink reversal procedure based on the
administration of heat and reducing agents (Fig. S1). Subsequent-
ly, the crosslinked extracts were passed over snowdrop lectin
(Galanthus nivalis agglutinin, GNA) agarose, a lectin which
specifically recognizes oligomannosidic N-glycans [30]. Eluate
fractions, when subjected to Western blotting analysis, document-
ed the presence of a subset of PrP
C in high-molecular weight
protein complexes that were specifically enriched by snowdrop
lectin agarose (Fig. 4). The binding to the affinity matrix was
determined to be specific by (i) the PrP
C-specific band pattern in
the eluate fraction demonstrating the selective capture of PrP
C in
high-molecular weight crosslinked complexes, rather than in its
uncrosslinked form; and (ii) the observation that pre-incubation of
the extract with soluble snowdrop lectin prevented affinity capture.
A crosslink reversal time series revealed that the high-molecular
weight complexes preferentially contain fully-glycosylated PrP
C
Figure 3. The mammalian prion protein family interactome. Network depicting proteins identified in spatial proximity to Dpl, PrP
C and Sho as
nodes and their direct or indirect interactions as spokes. Components identified in previous studies by other investigators are shown with red lines
surrounding and red edges connecting the nodes. The intensity of gray shading of nodes correlates directly with the fractional sequence coverage
with which individual components were identified. Increased spoke thickness indicates stronger co-enrichment with the connected bait protein.
Node shapes indicate predominant cellular localization of proteins, i.e. ER and Golgi compartments (rectangular), plasma membrane (oval), cytosol
(diamond) or secreted (octagonal). Nodes depicting proteins whose presence in the samples correlated strongest with the presence of a given bait
protein are arranged in spatial proximity to the respective bait protein nodes in the bottom half of the network.
doi:10.1371/journal.ppat.1000608.g003
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PrP
C present at the cell surface.
A subset of cellular P4hb, Pdia3 and calreticulin reside at
the cell surface of neuroblastoma cells
A conspicuous feature of the Dpl/PrP/Sho-interactome dataset
constituted the identification of multiple PDIs. In particular, Pdia3
(also known as ERp57) was represented with strong sequence
coverage (61%) and its identification was further corroborated by
similarly strong identifications for calnexin and calreticulin, known
interactors of this PDI. Whereas binding of PDIs to both Dpl and
PrP was expected due to the presence of internal disulfide bridges
in these proteins, co-segregation with Sho (Pdia3 117:114 iTRAQ
reporter ion ratio of 2:1), which does not carry a disulfide bridge,
was an unexpected finding. PDIs are known to harbor both
isomerase and chaperone functions. In light of previous calls for an
involvement of chaperone-like activities in the conversion of PrP
C
to PrP
Sc, we asked whether a subset of PDIs may play a role in this
process. It is currently thought that the conversion of PrP
C occurs
only after it has reached the cell surface [32,33], i.e. well-removed
from its presence within the ER where it would be expected to
encounter PDIs. Thus, if PDIs were involved in PrP
C conversion,
these proteins would also have to be present outside the ER,
preferably at the plasma membrane. Intriguingly, a small number
of reports suggest that, at least in some cells, this might indeed be
the case (please refer to Discussion section). To investigate whether
Pdia3, P4hb and calreticulin are also present at the cell surface in
mouse neuroblastoma cells, a cell surface biotinylation experiment
was undertaken. Cells were incubated for a brief duration with a
cell-impermeable biotin-labeling reagent, which conjugates to
primary amines through an N-hydroxysuccinimide ester group, or
were subjected to mock treatment. To determine the degree to
which broken cells were present at the time of cell surface
biotinylation, the downstream analysis was extended to histone 2B.
If a large amount of broken cells had been available, histone 2B
would have been present at appreciable levels in the cell culture
medium resulting in an unequal signal, absent in the mock-treated
sample and strong in the biotinylated sample. The observation
that histone 2B signals in streptavidin agarose eluates were equal
documented that low levels of non-biotinylated histone 2B had
been captured unspecifically and served as evidence that levels of
extract employed in the side-by-side streptavidin agarose capture
steps had indeed been equal. Western blot analysis of extract and
streptavidin eluate fractions probed with a PrP
C-specific antibody
served as a positive control (Fig. 5). Taken together this
Figure 5. Evidence for cell surface localization of a subset of
PDIs and calreticulin in mouse neuroblastoma cells. N2a and
ScN2a cells were subjected to cell surface biotinylation or mock
treatment. Subsequently, cellular extracts were side-by-side affinity
purified on a streptavidin agarose matrix. Extracts and streptavidin
agarose eluate fractions were analyzed by Western blotting and
membranes probed with antibodies directed against histone 2B, PrP,
P4hb, Pdia3 and calreticulin. The relative strength of P4hb-, Pdia3- and
calreticulin-specific signals present in eluate fractions from biotinylated
(lanes 6 and 8) versus non-biotinylated samples (lanes 5 and 7) is
consistent with the conclusion that a subset of these proteins resided at
the cell surface during the biotinylation step. The relative intensity of
P4hb- and Pdia3-derived signals in extract (40 mg total protein loaded
per lane) and eluate fractions can be estimated from the concomitant
analysis of 1/4 and 1/20 of the extract fraction shown in lane 1. Thus,
P4hb and Pdia3 signals in the eluate fraction (captured from 2 mg total
extract) were equivalent to or exceeded the amount of these proteins
present in 2 mg of extract. Please note the presence of histone 2B in all
eluate fractions (lanes 5–8), in support of the conclusion that the
protein binds unspecifically to the affinity matrix.
doi:10.1371/journal.ppat.1000608.g005
Figure 4. Evidence for PrP
C in high molecular weight protein
complexes captured by a lectin with specificity for oligoman-
nosidic glycans. Brain extracts from mice subjected to transcardiac
perfusion crosslinking were passed over snowdrop lectin agarose.
Western blot analysis of eluate fractions with 7A12 antibody
documented presence of PrP
C in high molecular weight complexes
(lane 5). Only weak bands were detected when the affinity capture step
was preceded by incubation of extracts with soluble snowdrop lectin
(sGNA, lane 2). Crosslink reversal by 5-min (lanes 3 and 6) or 20-min
(lanes 4 and 7) heat treatment of samples caused a shift of PrP
C reactive
bands to levels of fully glycosylated PrP
C consistent with the release of
PrP
C from crosslinked complexes.
doi:10.1371/journal.ppat.1000608.g004
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was enriched in streptavidin eluate fractions derived from in vivo
biotinylated cells compared to the corresponding samples derived
from mock-treated control cells. The possibility that this
distribution may have been the result of an unspecific binding to
the affinity matrix was excluded based on a comparison with
histone 2B signals observed evenly across all streptavidin eluate
fractions, a distribution expected for a protein which binds to the
affinity matrix unspecifically. A calculation based on a semi-
quantitative titration analysis of Western blot signal intensities
revealed that the relative amounts of PDIs and calreticulin at the
plasma membrane are small compared to their respective
quantities in the ER, but constitute at least 1:1000 of the total
amounts in these cells. Actual amounts may exceed these estimates
as the calculation did not account for the non-stoichiometric
labeling achieved during the biotin conjugation step and losses of
biotin-derivatized PDIs incurred during the streptavidin affinity
purification step.
Inhibitors of protein disulfide isomerases increase PrP
Sc
levels in a subset of ScN2a cell clones
We next addressed whether PDI-inherent chaperone activities
influence PrPconversion in prion-infected mouse neuroblastoma cells
(ScN2a). The identification of four different PDIs in the dataset
suggested that the knockdown of just one PDI may be uninformative.
Wetherefore employed inhibitorsknownto interfere broadlywiththe
activity of PDIs. One possible outcome of PDI inhibition invivo would
include a depression of PrP
Sc levels by inhibiting PDI-mediated
unfolding of an obligate precursor form of PrP
C. Interestingly, both
the addition of the dodecapeptide antibiotic bacitracin or 5,59-
dithiobis(2-nitrobenzoic acid) (DTNB), membrane-impermeable
reagents known to inhibit PDIs through noncovalent and covalent
modes of binding, respectively [34], caused an increase in the level of
proteinase K-resistant PrP
Sc (Fig. 6). The effect sizes correlated with
inhibitor concentrations applied, and in the presence of up to 1 mM
of either of the inhibitors, the viability of ScN2a cells (assessed by the
trypan blue dye exclusion assay) was not impaired during the course
of the experiment. A direct inhibitory effect of these reagents on the
proteinase K digestion itself can be ruled out, since levels of the faster
migrating PrP
Sc-derived signals, characteristic for the presence of
PrP
Sc in this disease model (attributed to the action of endogenous
proteases that produce a ‘‘trimming’’ of PrP N-terminal sequences
[35,36]), were similarly elevated even prior to the proteinase K
digestion step. This observation was made with two clones of ScN2a
cells obtained from independent sources; surprisingly, however, it
could not be observed with an isolate of chronically prion-infected
GT1 cells or two additional ScN2a clones derived from yet other
sources (Fig. S2), possibly indicating the existence of cell line- or
subclone-specific PDI family member expression profiles. We note
that variations in the behavior of different ScN2a cell clones are well-
documented, as is the occurrence of heteroploidy. While variations in
our experimental paradigm preclude a generalized observation, they
nonetheless put a spotlight on ER-derived chaperones that may
engage in physiological interactions with PrP
Ceven at the cellsurface,
as discussed below.
Discussion
The work presented here may comprise the most comprehen-
sive cell-based analysis of the PrP
C interactome to date.
Furthermore, it is, to our knowledge, the first study to extend
the PrP
C interactome characterization to other members of the
mammalian prion protein family. Critical technical advances from
previous PrP
C interactome work constitute the incorporation of
FLAG affinity purification tags and the use of iTRAQ-based
quantitative mass spectrometry for the discrimination of specific
from unspecific interactors. These conceptual choices greatly
facilitated bioinformatic analyses and afforded an in-depth glimpse
into the molecular environment of these proteins.
Figure 6. Inhibition of protein disulfide isomerases causes accumulation of PrP
Sc in a subset of ScN2a cell clones. A, Bacitracin or
DTNB, reagents known to inhibit PDIs through orthogonal modes of binding, were added at the indicated concentrations to the cell culture medium
and left on the ScN2a cells for a duration of 2 days. Following cell lysis, protein levels were adjusted and a subset of samples subjected to digestion
with proteinase K (lanes 411). All samples were analyzed by Western blotting with a PrP specific antibody. Please note the increase in intensity of low
molecular weight bands characteristic for the presence of PrP
Sc even without proteinase K treatment (lanes 1–3). B, A two-sample, two-tailed
Student’s t-test assuming unequal variance was utilized to determine the statistical significance of bacitracin-treated band intensities compared to
normalized untreated samples. The result of this analysis indicated a significant increase of PrP
Sc in ScN2a clones 1 and 2 treated with 1 mM
bacitracin (P-value=0.01).
doi:10.1371/journal.ppat.1000608.g006
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members of the mammalian prion protein family populate highly
similar molecular environments when expressed in neuroblastoma
cells. This interpretation is based on (i) the high degree of overlap
amongst candidate interactors identified for each of the three bait
proteins, and (ii) the reciprocal co-capture of endogenous prion
proteins in affinity purifications of FLAG-tagged bait proteins.
Due to the stringent washing steps applied following the FLAG
tag-dependent capture step, this observation is unlikely to
represent an unspecific co-enrichment of raft-like membrane
domains rich in GPI-anchored proteins. Instead, it points at a
close spatial proximity, if not direct interaction, of members of the
prion protein family at the plasma membrane. The possibility of a
direct interaction between Dpl and PrP
C had been raised
previously in a report demonstrating rescue of a Dpl-dependent
ataxic phenotype in two PrP-deficient (Prnp
0/0) mouse lines by
reintroduction of PrP
C [37]. Recently, a similar rescue of Dpl-
mediated toxicity was documented upon overexpression of PrP
C
or Sho in a primary cell culture model of cerebellar granule
neurons which exhibits undetectable endogenous levels of these
proteins [20]. However, it has remained unresolved whether these
observations depend on the spatial proximity of the respective
proteins as opposed to action upon other proteins in shared or
intersecting biochemical pathways.
The comparison of protein-protein interaction data reported
here with previous data based on either the immunocapture of
endogenous PrP
C [16] or myc-tagged transgenic PrP
C [38]
harvested from mouse brains suggests that the move to a cell
model may, together with the increase in scale, contributed to a
reduction in protein ‘noise’ and thereby an enhanced analysis
depth. As a result, the study revealed spatial proximity of the bait
proteins to multiple proteins (NCAM, LRP, Na/K ATPase and
PDIs) which had previously been proposed to bind to PrP
C in the
context of widely-differing experimental paradigms.
A comparison of input and eluent protein amounts in this study
suggests that less than 0.1% of membrane-associated proteins
present in the crosslinked cellular extracts were withdrawn by
individual immunoaffinity capture steps. The strength with which a
given protein was identified in proximity to our bait proteins may at
least partially reflect its relative abundance in the vicinity of the bait
protein. Multiple lines of evidence in our dataset support the notion
that candidate proteins we identified do indeed reside naturally in
spatial proximity to members of the mammalian prion protein in
vivo: (1) the proteins we identified originate from cellular
compartments to which PrP
C is expected to localize; (2) some
highly abundant cellular proteins (tubulin, actin, histones) were only
seen in the list of unspecific binders to the affinity matrix; (3) no
nuclear proteins were found despite the use of deoxycholate in the
cell lysis buffer, a detergent known to solubilize nuclear membranes;
and (4) ten out of about fifty candidate interactors in the dataset had
previously been reported to interact with the cellular prion protein.
The majority of candidate interactors identified in this work (e.g.
PDIs, calreticulin, LRP, 14-3-3 proteins and Na/K ATPase) are
known to be widely expressed across a large number of diverse
tissues and as such are plausible interactors of the bait proteins also
outside of N2a cells. Other interactors exhibit a more restricted
tissueexpression andareprimarily knownfortheir expression incell
types belonging to the neuronal lineage (e.g. NCAM and L1), in
agreement with the predominant and partially overlapping
expression of PrP
C and Sho in a subset of these cell types. For
Dpl, a protein normally confined to the testis, a physiological
proximityto some oftheseproteinsis unlikely,exceptintheartificial
experimental circumstances (described above) which result in
ectopic expression of Dpl in the brain.
Proteins that are expected to engage in short-lived interactions
are typically underrepresented in interactome datasets of this kind,
and as such it was not surprising to find that enzymes known to
modify N-glycans or responsible for attachment of the GPI anchor
to PrP
C were not identified. Moreover, it is likely that the
crosslinking chemistry we employed may have precluded the
detection of some interactions which lack suitably-positioned
functional groups required for the generation of productive
covalent bonds. A bias towards covalent interactions that do not
sterically block the FLAG epitope may have further skewed the
dataset. The above note of caution should also be extended to
instances in which candidate interactors co-purify only with a
subset of the bait proteins, as seen here for the largely
uncharacterized proteins Fam3C and C1orf75 that co-purified
with Dpl and Sho, respectively. More work will be needed to
determine whether this apparent selective binding to a subset of
bait proteins represents a technical artifact or reflects underlying
differences in the biology of the bait proteins.
The conversion of the cellular prion protein has repeatedly been
proposed to involve additional host-encoded factors. In particular,
the participation of chaperones in this process has remained an
attractive hypothesis based on theoretical considerations and
species barrier effects [39]. Any chaperone to fulfill this role would
be expected to bind to PrP
C and reside at the cellular plasma
membrane. The latter conclusion can be drawn from multiple
lines of investigation in cell models of prion disease [32,33]. This
study revealed multiple chaperone molecules such as Pdia3, P4hb
and calreticulin that may share these characteristics. The
subsequent observation that pharmacological inhibition of PDIs
causes an increase in proteinase K-resistant PrP
Sc levels in a subset
of ScN2a cell clones is exciting as it suggests PDIs may, under
certain circumstances, be protective in the context of prion disease,
thereby extending observations from an earlier report which
documented an increase in Pdia3 levels in prion infected mice and
an inverse correlation of PrP
Sc toxicity and Pdia3 expression levels
in mouse neuroblastoma cells [40]. Consistent with a more direct
role in PrP conversion reactions, PDIs have been shown to localize
to lipid rafts in other cell systems [41], and experiments which
employed an in vitro PrP
Sc amplification methodology suggested
that free sulfhydryl groups — through an unidentified mechanism
— play a critical role in this reaction [42]. The cellular disulfide
exchange homeostasis is a complex aspect of cell biology due to the
existence of more than ten PDI family members in mammals with
distinct but only partially understood substrate specificities, cellular
localizations and intricate regulations [43]. The scope and
emphasis of this study was such that it could only begin to address
the role these molecules may play in prion biology. However, it is
attractive to hypothesize that some cells may put a low ER leakage
rate of PDIs to good use by employing these molecules to ‘‘patrol’’
their plasma membrane and prevent undesired occurrences of
protein misfolding. In disease, or when pharmacologically
suppressed, the rate of misfolding may exceed the rate of PDI-
mediated rescue and thus produce a net accumulation of PrP
Sc.
Similar concepts implicating rates of synthesis and degradation
have been proposed in a ‘dynamic susceptibility’ model based on
observations in N2a cells [44].
Similar to PDIs, calreticulin — in addition to its well established
role in the ER — may play an important function in cell-cell
recognition in apoptosis and cell-surface recognition during
cellular attachment to laminin [45]. This is relevant in the current
context as multiple lines of evidence suggest that PrP
C confers
protection against apoptosis and plays a role in adhesion to the
extracellular matrix [46]. While it remains to be determined
whether the spatial proximity of PrP
C and calreticulin plays a role
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binding to laminin depends on the presence of oligomannosidic N-
glycans on laminin [47,48]. The link to oligomannose-carrying N-
glycans was intriguing because the same posttranslational
structures had also been signaled by a comprehensive bioinfor-
matic analysis to which our dataset was subjected. The latter
pointed to a previously reported similarity in the ability of NCAM
and basigin, two proteins we identified with high sequence
coverage, to bind to oligomannose-bearing membrane proteins
through a specialized Ig-like domain. Surprisingly, scrutiny of the
dataset for proteins reported to carry this posttranslational
modification subsequently established their strong enrichment. A
snowdrop lectin binding experiment then confirmed that PrP
C
indeed resides in spatial proximity to proteins carrying oligoman-
nosidic N-glycans in the intact mouse brain. From these
observations, a model emerged based on which members of the
mammalian prion protein family may primarily ‘organize’ their
molecular microenvironment by binding to NCAM and basigin
which in turn recognize a small subset of proteins carrying N-
glycans of the rare oligomannose type. The latter proteins may
themselves be part of protein assemblies containing more than one
component.
One of these assemblies surrounds the oligomannosidic
carbohydrate-carrying b-subunit of the Na/K ATPase (Atp1b3),
a protein complex known to also consist of an a-subunit and a
tightly associated G-protein complex, both of which were observed
in this dataset and an earlier PrP
C interactome investigation based
on in vivo crosslinked proteins in the mouse brain [16]. Recently, a
role for the cellular prion protein in lactate metabolism has been
proposed [49]. The authors also documented interactions of PrP
C
within a molecular assembly involving basigin and sodium/
potassium channels. Our data corroborate key interactions
proposed in this initial study and documented that this novel
concept is not restricted to PrP
C but also extends to Dpl and Sho.
A molecule which may participate in multiple sub-nodes is the
integrin b1 subunit (Itgb1). In addition to Itgb1, our data
documented spatial proximity of all three bait proteins to the
laminin-specific integrin a6 (Itga6) and the integrin av (Itgav). The
binding of bait proteins to these integrins is unlikely to have
occurred independently of Itgb1 binding, because stable Itgb1–
Itgav (integrin avb1) or Itgb1–Itga6 (integrin a6b1, also known as
VLA-6) heterodimericcomplexes are well described in the literature
[50]. VLA-6 plays an important role in the adhesion of cells to
laminin and in this capacity has been shown to associate with ecto-
calreticulin [51] or LRP [52]. The identification of LRP (Rpsa),
better known as the 37-kDa/67-kDa laminin receptor in the prion
research field and currently under investigation as a therapeutic
target for prion disease [53,54,55], corroborated previous experi-
ments documenting its spatial proximity to PrP
C (and possibly Dpl
[56,57]) and was complemented by the identification of ribosomal
protein S21 (Rps21), a protein which not only can bind to LRP but
shares with the latter the ability to exert a ribosome-independent
function at the plasma membrane [58,59]. Finally, Itgb1-containing
integrins may functionally interact with CD98 (Slc3a2), a type II
TM protein [60,61]. The circle to basigin can be closed by a well-
established interaction between CD98 and basigin [62,63].
Although the details of this interaction are far from understood, it
has been suggested that binding of CD98 to basigin may play a role
in cell fusion control, including the specialized fusion of a sperm to
the membrane of an egg that precedes fertilization [64,65,66].
Given the independently proposed role of Dpl in sperm fusion
events [67], it will be of interest to determine whether the direct
interaction of Dpl with the above protein machinery bears
functional significance in this context.
During the assembly of this work, a systems biology study
reported on global changes in protein expression during the course
of prion disease in mice [68]. Not surprisingly, a comparison of the
two datasets revealed little overlap in the proteins which we found
to reside in proximity to PrP
C and the proteins whose (mRNA)
expression is affected in disease. This finding is consistent with an
interpretation that global responses to prion disease may not
center on proteins which are spatially close to PrP
C and also the
distinct technological bases of the two datasets. A notable
exception to this observation may represent proteins from the
ZIP metal ion transporter family of which two paralogs were found
in the vicinity of PrP
C in this study (ZIP6 and ZIP10), and another
paralog ZIP14 was found to be upregulated during the course of
prion disease in five independent mouse strains. Interestingly,
these three ZIP proteins belong to a common branch (referred to
as the LIV-1 subfamily) within mammalian ZIP paralogs whose N-
terminal extracellular domain harbors features that are strikingly
reminiscent to sequence features found within members of the
mammalian prion protein family itself. Extensive follow-up
investigations have led to the surprising conclusion that the
mammalian prion gene family is phylogenetically derived from a
ZIP ancestor molecule (Schmitt-Ulms et al., in revision).
The possible participation of PrP
C family members in both
lactate metabolism and laminin adhesion are unlikely to represent
independent functional specializations exerted in the setting of
distinct protein microenvironments. Arguing against such a
scenario are (i) the known interactions between molecules we
identified in close proximity to members of the mammalian prion
proteins, and (ii) the recurring theme of oligomannosidic N-glycans
which emerged from the bioinformatic analysis. Instead, a unifying
model came into focus which suggests that the involvement of
PrP
C in these biological functions is mediated by remarkably
interconnected molecular machineries. In proposing the model, it
was not our intent to oversimplify a complex molecular biology
that surely must underlie interactions in this network. It is, for
example, likely that connections amongst proteins in this network
are not arranged in a chain-like and static fashion through a series
of single contact sites. Rather, a more realistic representation of
such a network would predict a system built upon highly
cooperative and dynamic interactions.
Conclusion
Taken together, this work suggests that members of the prion
protein family may be embedded in specialized membrane
domains characterized by an extended molecular network which
supports functions in adhesion control, lactate metabolism and cell
fusion events. Our investigation leads to the conclusion that
biochemical interactions among the members of the mammalian
prion protein family exist. It confirms multiple candidate
interactors of PrP
C in a unified paradigm including an
independent verification of the laminin receptor precursor (LRP)
as an authentic PrP interactor. It thereby not only reconciles a
fragmented literature, but should facilitate future efforts to further
define the relative contribution of these interactors to the biology
of PrP
C. Novel interactors uncovered in this study paint a coherent
picture based on which an argument for the spatial proximity of
NCAM, basigin, Na/K ATPase and LRP can be made, even
independent of their ability to bind to PrP
C. Moreover, data
presented here raise many new questions as to (i) whether
biological outputs of PrP
C implied by the ‘‘guilt-by-association’’
logic will be confirmed, (ii) the importance of oligomannosidic N-
glycans for the structural integrity and assembly of the molecular
environment of PrP
C, (iii) the role which a subset of cellular
chaperones may play in PrP biology and disease, and (iv) the exact
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C. It is hoped that
this work will stimulate investigations which will not only resolve
these questions, but lead to insights from which a therapeutic
strategy for addressing prion diseases can be derived.
Materials and Methods
Ethics statement
All procedures which required the handling of mice were
conducted in accordance with an animal use protocol
(No. 20006633) approved by the University of Toronto Animal
Care Committee.
Antibodies
The mouse monoclonal antibody directed against PrP (clone
7A12) was a generous gift from Dr. Man-Sun Sy (Case Western
Reserve University School of Medicine, Cleveland, OH, USA).
The anti-FLAG M2 antibody (F3165) was obtained from Sigma-
Aldrich (Oakville, ON, Canada). Anti-ERp57 (Pdia3) antiserum
was raised against glutathione S-transferase-fused mouse ERp57.
Anti-P4hb antiserum (SPA-891) was purchased from StressGen
Biotechnologies (Victoria, BC, Canada).
Clones
FLAG affinity tags (N-DYKDDDDK-C) were inserted before
residue 29 of mouse PrP, residue 27 of mouse Dpl, and residue 26
of mouse Sho (all in the pcDNA3 mammalian expression vector)
using standard PCR-based mutagenesis techniques. The identity
of all constructs was verified by DNA sequencing.
Cell culture, in vivo crosslinking, inhibitor treatments and
cell viability assay
Cell culture and formaldehyde crosslinking of N2a cells followed
a protocol described before [10]. For bulk selection of stably
transfected cells, cultures were expanded in the presence of 1 mg/
mL G418 and maintained at a concentration of 0.2 mg/mL
G418. RML-infected N2a cells (ScN2a) were maintained as above.
For PDI inhibition experiments, DTNB or bacitracin (Sigma-
Aldrich) was added to the cell culture medium at indicated
concentrations followed by a two-day incubation at 37uC. The
effect of inhibitor treatments on cell viability was assessed by the
Trypan blue dye exclusion assay. Briefly, 0.4% Trypan blue was
gently mixed with trypsinized cells and incubated for 5 minutes at
room temperature. Subsequently, the percentage of viable cells per
volume equivalent was determined with the use of a hemocytom-
eter.
Affinity purification of bait proteins
Approximately 10
9 in vivo FA-crosslinked cells each of control
and FLAG-prion expressing N2a cell lines were lysed in
homogenization buffer (50 mM NH4Cl, 80 mM Tris, pH 8.0)
supplemented with 16 Complete Protease Inhibitor Cocktail
(Roche, Palo Alto, CA, USA). To ensure near quantitative
extraction of membrane proteins, an equal volume of extraction
buffer (20 mM NaCl, 1% sodium deoxycholate, 1% NP-40,
20 mM Tris, pH 8.0) was added, followed by a 30-min incubation
and 5-min sonication in a water bath sonicator. Insoluble cellular
debris was removed by high-speed centrifugation (100,0006g,
1 h). Subsequently, the crosslinked bait protein complexes were
immunoaffinity-captured on anti-FLAG-agarose (Sigma-Aldrich).
During this step samples were gently agitated on a turning wheel
for 12 h, then washed extensively with 0.5 M NaCl, 0.05% SDS,
1% NP-40, 20 mM HEPES, pH 7.3, and detergents removed by a
pre-elution wash with 10 mM NH4HCO3, pH 8.0. Proteins were
eluted by acidification with 0.2% trifluoroacetic acid, 20%
acetonitrile, pH 2.0.
Protein reduction, alkylation and trypsinization
Protein-containing fractions were denatured in the presence of
6 M urea, 20 mM NH4HCO3, pH 8.0, followed by reduction
with 1 mM tris-(2-carboxyethyl)-phosphine for 30 min at 60uC
and alkylation with 2.5 mM 4-vinylpyridine for 1 h at room
temperature in the dark. Samples were diluted four-fold to ensure
that the concentration of urea did not exceed 1.5 M. Tryptic
digestion was initiated by the addition of 1% (wt/wt) of side chain-
modified, TPCK-treated porcine trypsin and allowed to proceed
at 37uC for 6 h.
iTRAQ labeling
Following trypsinization, equal quantities of tryptic peptide
mixtures were spiked with 1 pmol of synthetic (Glu1)-Fibrinopep-
tide B (GluFib) (Sigma-Aldrich) to serve in the downstream
analysis as an internal control for the efficiency of individual
labeling reactions. Equal labeling with all four reagents was
confirmed by equal intensities of 114:115:116:117 signature peaks
upon forced fragmentation of the GluFib [M+2H]
2+ parent ion at
m/z 785.85. Any strong deviation from this ratio would have
indicated problems with the labeling reaction or recovery of
individual samples prior to the sample mixing step. Individual
iTRAQ labeling reagents (Applied Biosystems, Foster City, CA,
USA) were reconstituted in ethanol, added to peptide mixtures
derived from the tryptic digestion of IP eluates (Control: iTRAQ
114, Dpl: iTRAQ 115, PrP: iTRAQ 116, Sho: iTRAQ 117) and
incubated at room temperature in the dark for 3 h.
Two-dimensional liquid chromatography
Strong cation exchange (SCX) chromatography was used to
achieve peptide fractionation of the complex digest mixture.
Samples digested with trypsin were adjusted to 25% acetonitrile
and acidified (pH 3.0) by 20-fold dilution in 25% acetonitrile,
20 mM KH2PO4, pH 3.0. High performance liquid chromatog-
raphy (HPLC) was carried out using the Ultimate System (Dionex,
Sunnyvale, CA, USA) equipped with a microflow calibration
cartridge, a Valco injection port and a 180 nL volume UV cell.
Separation was achieved on a self-packed 0.5 mm6110 mm Luna
SCX column (Phenomenex, Torrance, CA, USA) at a flow rate of
18 ml/min with a steep salt gradient from 0–400 mM NH4Cl in
25% acetonitrile, 20 mM KH2PO4, pH 3.0. Fractions eluted from
the SCX column were desalted with C18 Empore (3 M,
Minneapolis, MN, USA) stop and go extraction (STAGE) tips
and subsequently subjected to nano-flow RP-HPLC using the
Ultimate LC system (Dionex, Sunnyvale, CA, USA) equipped with
a nanoflow calibration cartridge at a flow rate of 250 nL/min.
Peptides were separated on a 75-mm ID self-packed column
containing Proteo C12 reverse-phase matrix (Phenomenex) using a
100-min gradient from 2%–34% acetonitrile in water, with 0.1%
(wt/vol) formic acid as the ion-pairing agent.
Electrospray ionization QqTOF mass spectrometry
analysis
The column effluent was coupled directly via a fused silica
capillary transfer line to a QSTAR XL hybrid quadrupole/time-
of-flight tandem mass spectrometer (Applied Biosystems; MDS
Sciex, Concord, ON, Canada) equipped with a MicroIonSpray
source. The progress of each LC/MS run was monitored by
recording the total ion current (TIC) as a function of time for ions
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gradient, a mass spectrum was acquired for 1 s, followed by one
collision-induced dissociation (CID) acquisition of 4 s each on ions
selected by preset parameters of the information-dependent
acquisition (IDA) method, using nitrogen as the collision gas.
Singly-charged ions were excluded from CID selection. The
collision energy was adjusted automatically for each CID spectrum
using an empirically-optimized formula which considers the
charge state and m/z value of the precursor ion.
Database searches
Peak lists for database searching were created using Mascot
Distiller (Version 1; MatrixScience, London, UK). Searches were
performed using designated MS/MS data interpretation algo-
rithms within Protein Prospector (Version 4.21.3; University of
California, San Francisco, CA, USA) [69] and Mascot (Version
2.2; MatrixScience). Searches considered up to one missed
cleavage and charge states ranging from +2t o+4. The analysis
of iTRAQ data was assisted by the software program ProteinPilot
(Version 2.0; Applied Biosystems; MDS Sciex). For a protein to be
listed in the data tables, it had to be identified by all three search
algorithms. All proteins listed in the table were identified with high
confidence by the application of the following filters: (i) CID
spectra with individual confidence scores of less than 80% were
not included (the determination of these confidence scores is
documented in the Protein Pilot 2.0 Software Help); (ii)
assignments to non-iTRAQ-labeled peptides were not considered;
(iii) all identifications of proteins had to be based on at least two
CID spectra. Raw iTRAQ ratios were corrected for impurity
levels of individual reagent lots determined by the manufacturer.
In instances where only two peptides supported the identification
of a protein, we required the underlying CID spectra to generate a
Mascot score indicating a ,5% probability that the match could
be considered a random event and further confirmed matches by
manual interpretation of spectra. As searches were carried out
without species restriction, the correct assignment of matches to
mouse entries served as an additional internal control. Identifica-
tions were confirmed in repeat experiments performed at a two-
fold lower scale. It should be noted that the vast majority of
proteins were identified with Mascot scores exceeding thresholds
conventionally applied for confident identifications. The mass
tolerance range between expected and observed masses used for
database searches was 6150 ppm for MS peaks, and 60.15 Da
for MS/MS fragment ions. These relatively large thresholds were
used to capture more of the low intense peaks that frequently
display broader distribution and are therefore assigned with lower
mass accuracy. Threshold levels were optimized based on LC/
MS/MS datasets of tryptic digests of standard proteins. All
samples were searched against the National Center for Biotech-
nology Information nonredundant database (nrNCBI, release:
June 2008) and a ‘decoy’ database in which all entries of the above
NCBI database had been inverted. The interactome diagram was
constructed using Cytoscape 2.6.0 [70].
Snowdrop lectin affinity purification
Mice were subjected to time-controlled transcardiac perfusion
crosslinking and brain extracts generated as described before [16].
Brain extracts which had been cleared of all insoluble content by
high speed centrifugation (100,0006g, 1 hr) were added to
snowdrop (Galanthus nivalis) lectin agarose (Sigma-Aldrich), which
had been pre-equilibrated in Lysis buffer (50 mM Tris, pH 8.3,
150 mM NaCl, 0.5% NP-40, 0.5% sodium deoxycholate, 16
Complete Protease Inhibitor), and incubated on an end-over-end
turning wheel for 12 h at 4uC. Following extensive washes with
lysis buffer, proteins were eluted by incubation of lectin agarose
beads with 16Laemmli sample buffer containing 100 mM DTT.
To generate the crosslink reversal series, snowdrop lectin agarose
eluate fractions were subjected to 90uC heat treatment for the
indicated durations.
Cell surface biotinylation
N2a and ScN2a cells, grown to 90% confluency, were washed
three times with 10 ml of ice-cold PBS and subsequently subjected
to biotinylation with 0.5 mg/ml HOOK-Sulfo-NHS-SS-Biotin
(Pierce Biotechnology, Rockford, IL, USA) in PBS for a duration
of 30 min at 4uC. Residual biotin was quenched by the addition of
100 mM glycine in PBS and further incubation for 15 min.
Following cell lysis in detergent containing buffer (0.5% NP40,
0.5% DOC, 150 mM NaCl, 16 Complete Protease Inhibitor
Cocktail) the capture of biotinylated proteins on streptavidin
agarose (Sigma-Aldrich) occurred during a 12 h incubation.
Following extensive washing with lysis buffer, captured proteins
were eluted by reducing the disulfide bond within the HOOK-
Sulfo-NHS-SS Biotin conjugation reagent in the presence of
100 mM DTT, 62.5 mM Tris, pH 6.8, 2% SDS.
Proteinase K digestion
Confluent cells were lysed in 10 mM Tris-HCl, pH 8.0;
100 mM NaCl; 0.5% NP-40; 0.5% sodium deoxycholate
(DOC). Equal amounts of protein determined using the bicinch-
oninic acid (BCA) reagent were digested with 20 mg/ml PK
(GIBCO, Carlsbad, CA, USA) at a ratio of 1:25 (w/w protease to
protein) for 1 h at 37uC. Reactions were stopped by the addition of
2 mM phenylmethylsulfonyl fluoride (PMSF). Following ultracen-
trifugation, pellets were resuspended in SDS-loading buffer and
subjected to immunoblot analysis.
Supporting Information
Figure S1 Evidence for PrP
C in high-molecular weight protein
complexes. Brain extracts from mice subjected to transcardiac
perfusion crosslinking were passed over a size exclusion chroma-
tography column. Western blot analysis of eluate fractions with
7A12 antibody documented the presence of PrP
C in high-
molecular weight complexes which co-eluted together with
calibration proteins spanning a molecular weight range of
669 kDa (lane 1) to 440 kDa (lane 3) to 160 kDa (lane 5).
Crosslink reversal by 20-min heat treatment of samples caused a
shift of PrP
C reactive bands to levels of fully glycosylated PrP
C
consistent with the release of PrP
C from crosslinked complexes
(lanes 2, 4 and 6). Th, thyroglobulin; Ft, ferritin; Ig, immuno-
globulin; Lg, lactoglobulin.
Found at: doi:10.1371/journal.ppat.1000608.s001 (0.11 MB PDF)
Figure S2 Inhibition of protein disulfide isomerases shows no
effect on PrP
Sc formation in a subset of ScN2a cell clones.
Bacitracin was added at the indicated concentrations to the cell
culture medium and left on the ScN2a clone 3 cells for a duration
of 2 days. Following cell lysis, protein levels were adjusted and a
subset of samples subjected to digestion with proteinase K. All
samples were analyzed by Western blotting with a PrP specific
antibody. Please note the absence of an effect on PrP
Sc levels in
this cell clone.
Found at: doi:10.1371/journal.ppat.1000608.s002 (0.10 MB PDF)
Table S1 Complete quantitative interactome dataset of prion
protein family in mouse neuroblastoma cells.
Found at: doi:10.1371/journal.ppat.1000608.s003 (0.94 MB PDF)
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